Subscribe To
Trinity biotech stock surges after $45m capital infusion from korea-based firm
Trinity Biotech plc (NASDAQ: TRIB) announced a $45 million investment and partnership with MiCo Ltd, a KOSDAQ-listed and Korea-based company. MiCo...
April 11, 2022, 11:54 am
Integer adds proprietary biomaterial technologies via €120m acquisition
Integer Holdings Corporation (NYSE: ITGR) acquired Connemara biomedical Holdings Teoranta and its su...
April 7, 2022, 1:01 pm
Pharmadrug advances dmt-analogue glaucoma program with fabrication of medical device to lower intraocular pressure
PharmaDrug Inc announced that, in collaboration with the Terasaki Institute for biomedical Innovation ...
April 7, 2022, 9:27 am
Medx signs distribution agreement with vitamed biomedical to launch its teledermatology screening platform in italy
MedX Health Corp. (TSX-V:MDX) said it has signed a commercial distribution agreement with Vitamed biomedical ...
April 4, 2022, 9:57 am
T2 biosystems secures additional barda funding to develop blood test panels to detect sepsis-causing pathogens
The biomedical Advanced Research and Development Authority (BARDA) is providing an additional $4.4 mil...
April 1, 2022, 11:05 am
Talis biomedical corporation (tlis) ceo rob kelly on q4 2021 results - earnings call transcript
Talis biomedical Corporation (TLIS) CEO Rob Kelly on Q4 2021 Results - Earnings Call Transcript...
March 15, 2022, 10:09 pm
Clearside biomedical, inc. (clsd) ceo george lasezkay on q4 2021 results - earnings call transcript
Clearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q4 2021 Results - Earnings Call Transcript...
March 10, 2022, 9:17 pm
Clearside biomedical, inc. (clsd) q4 earnings and revenues beat estimates
Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of 244.44% and 95.19%, respectively, for the quarter ended December 2021. D...
March 10, 2022, 6:48 pm
Pharmadrug announces positive results from dmt-analogue program to treat glaucoma
PharmaDrug Inc announced that it has successfully completed a head-to-head potency comparator study of its two undisclosed DMT-analogue candidates for...
February 23, 2022, 9:10 am
Pharmadrug announces positive results from dmt-analogue program to treat glaucoma
PharmaDrug Inc announced that it has successfully completed a head-to-head potency comparator study of its two undisclosed DMT-analogue candidates for...
February 23, 2022, 9:10 am
Pharmadrug announces positive results from dmt-analogue program to treat glaucoma
PharmaDrug Inc announced that it has successfully completed a head-to-head potency comparator study of its two undisclosed DMT-analogue candidates for...
February 23, 2022, 9:10 am
Petvivo holdings, inc. to announce results for third quarter ended december 31, 2021 [updated]
MINNEAPOLIS, MN, US, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging ...
February 3, 2022, 6:05 pm
Petvivo holdings, inc. to announce results for third quarter ended december 31, 2021 [updated]
MINNEAPOLIS, MN, US, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging ...
February 3, 2022, 6:05 pm
Petvivo holdings, inc. to announce results for third quarter ended december 31, 2021 [updated]
MINNEAPOLIS, MN, US, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging ...
February 3, 2022, 6:05 pm
Psychedelics biotech startup launches phase 1 study on ayahuasca's active ingredient
Psychedelics biotech startup Entheon biomedical ENBI ENTBF announced the approval by the local Dutch et...
February 3, 2022, 1:53 pm
Psychedelics biotech startup launches phase 1 study on ayahuasca's active ingredient
Psychedelics biotech startup Entheon biomedical ENBI ENTBF announced the approval by the local Dutch et...
February 3, 2022, 1:53 pm
Psychedelics biotech startup launches phase 1 study on ayahuasca's active ingredient
Psychedelics biotech startup Entheon biomedical ENBI ENTBF announced the approval by the local Dutch et...
February 3, 2022, 1:53 pm
4 top biotech stocks to gain amid industry challenges
New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks biomedica...
February 1, 2022, 9:59 am
4 top biotech stocks to gain amid industry challenges
New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks biomedica...
February 1, 2022, 9:59 am
4 top biotech stocks to gain amid industry challenges
New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks biomedica...
February 1, 2022, 9:59 am